CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $763,006 | -1.3% | 49,258 | +1.6% | 0.00% | 0.0% |
| Q1 2024 | $772,851 | -29.5% | 48,485 | -25.6% | 0.00% | -50.0% |
| Q4 2023 | $1,095,591 | +135.7% | 65,175 | +63.9% | 0.00% | +100.0% |
| Q3 2023 | $464,759 | -24.4% | 39,757 | -13.0% | 0.00% | 0.0% |
| Q2 2023 | $614,437 | -1.6% | 45,717 | +21.4% | 0.00% | 0.0% |
| Q1 2023 | $624,320 | +29872.2% | 37,655 | +33520.5% | 0.00% | – |
| Q4 2022 | $2,083 | +108.3% | 112 | +12.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |